A human monoclonal antibody blocking SARS-CoV-2 infection
Vaccines and targeted therapeutics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are currently lacking. Here, the authors report a human monoclonal antibody capable of neutralizing both authentic SARS-CoV and SARS-CoV-2 by targeting a common epitope.
Guardado en:
Autores principales: | Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, Frank J. M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, Berend-Jan Bosch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d72494b81b034a06b5cf561dbf0e29c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
por: Chunyan Wang, et al.
Publicado: (2020) -
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
por: Chunyan Wang, et al.
Publicado: (2021) -
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
por: Roos M. de Jong, et al.
Publicado: (2021) -
Development and characterization of a monoclonal antibody blocking human TRPM4 channel
por: See Wee Low, et al.
Publicado: (2021) -
Nonhuman primate models for SARS.
por: Bart L Haagmans, et al.
Publicado: (2006)